Through thousands of years of reciprocal coevolution, Mycobacterium tuberculosis has become one of humanity's most successful pathogens, acquiring the ability to establish latent or progressive infection and persist even in the presence of a fully functioning immune system. The ability of M. tuberculosis to avoid immune-mediated clearance is likely to reflect a highly evolved and coordinated program of immune evasion strategies that interfere with both innate and adaptive immunity. These include the manipulation of their phagosomal environment within host macrophages, the selective avoidance or engagement of pattern recognition receptors, modulation of host cytokine production, and the manipulation of antigen presentation to prevent or alter the quality of T-cell responses. In this article we review an extensive array of published studies that have begun to unravel the sophisticated program of specific mechanisms that enable M. tuberculosis and other pathogenic mycobacteria to persist and replicate in the face of considerable immunological pressure from their hosts. Unraveling the mechanisms by which M. tuberculosis evades or modulates host immune function is likely to be of major importance for the development of more effective new vaccines and targeted immunotherapy against tuberculosis.
Mycobacterium tuberculosis is an extremely successful pathogen that appears to have coevolved with humans as its specific host species for thousands of years (1) . This persistent relationship has uniquely shaped the mycobacterial genome to encode mechanisms that enable the bacilli to resist attack and elimination by the human immune system. Although both innate and adaptive immunity clearly modify the course of M. tuberculosis infection, this organism can persist and cause disease even in fully immunocompetent hosts. In addition, the currently available vaccine for prevention of tuberculosis, the attenuated Mycobacterium bovis strain known as bacille Calmette-Guérin (BCG), has proven largely ineffective despite widespread use. This resistance to host immunity most likely reflects a highly evolved and multifactorial ability of pathogenic mycobacteria to prevent or evade effective host responses. A more complete understanding of how this occurs will likely be crucial to the design and production of better vaccines for prevention of tuberculosis. In this review we summarize current knowledge and recent advances in the study of immune evasion by M. tuberculosis.
EVASION OF INNATE IMMUNITY
The cellular arm of the innate immune system relies primarily on an array of germline-encoded receptors for pathogen recognition (2) . These pattern recognition receptors are composed of members of the Toll-like receptor (TLR), nuclear oligomerization domain (NOD) pathogen clearance not only ensures the survival of M. tuberculosis in the host environment, but also limits the development of potentially more potent adaptive immune responses (8) .
EVASION OF TLR SIGNALING
M. tuberculosis has many diverse lipoprotein and lipoglycan moieties that can be recognized by TLR2 heterodimeric complexes, including products encoded by lpqH (19-kDa lipoprotein) and the lpr gene family (9) (10) (11) (12) . These are expressed largely on the bacterial cell wall and have been shown to be a significant component of secreted membrane vesicles implicated in TLR2dependent macrophage activation, cytokine production, and granuloma formation (13) . Roles, possibly redundant, for TLR4 and TLR9 in the innate response to M. tuberculosis have been described in mouse models (14) (15) (16) . These receptors share a common signal transduction pathway, which depends on the adaptor molecule myeloid differentiation factor-88 (MyD88). Mice lacking MyD88 are highly susceptible to aerogenic M. tuberculosis infection, with a mean time to death of approximately 42 days (17) , but this appeared to be due mainly to the role of MyD88 in interleukin-1R (IL-1R) signaling, and not in the TLR2, TLR4, or TLR9 activation pathways (18, 19) . The importance of this MyD88-dependent pathway to M. tuberculosis immunity, while clearly established in mouse models, remains uncertain in humans because rare individuals with an inborn deficiency in MyD88 or IRAK-4 (a necessary MyD88 signaling intermediate) have not yet been found to display enhanced susceptibility or morbidity to mycobacterial infections (20) .
Some reports have suggested that TLR9 signaling, which promotes T H 1 immunity, is actively antagonized by the TLR2-dependent depletion of intracellular IL-1 receptor associated kinase-1 (IRAK1) (21, 22) . TLR2 signaling may also constrain optimal immune activation during M. tuberculosis infection and eventually downmodulate antigen-specific CD4 T cell priming through the production of IL-10 (23, 24) . The TLR2 agonist lipoarabinomannan (LAM) from nonpathogenic mycobacterial cell walls is highly immunogenic, but mannose-capped LAM (ManLAM) from virulent mycobacterial species is not. This modification confounds the capacity of this abundant cell wall glycolipid to initiate interferon-γ (IFN-γ) receptor signaling in macrophages, IL-12p70 production by dendritic cells, phagosomal maturation, and apoptosis of infected cells (25) . In accordance with these observations, some studies of TLR2 polymorphisms in humans have found associations with enhanced susceptibility to pulmonary tuberculosis, although this has not been observed in all cases (26) (27) (28) (29) (30) (31) (32) (33) (34) . Together, these data suggest that M. tuberculosis has taken advantage of the TLR2 pathway to modify the host environment to be more amenable for latent disease and persistence.
EVASION OF NLR SIGNALING
For many years it was generally believed that M. tuberculosis resided exclusively within a modified endosomal compartment after entering host phagocytic cells and did not gain access to the cytosol at any stage during its intracellular life cycle. However, as early as 1993 data began to appear that suggested an ability of virulent M. tuberculosis to escape from phagosomes into the cytosol of infected macrophages in a coordinated and controlled fashion (35, 36) . This has been strongly confirmed in more recent studies of infected human monocyte-derived dendritic cells, which used elegant electron-microscopy imaging to show convincingly that virulent mycobacteria periodically escape from phagolysosomes via a pathway that is dependent on the Early Secretory Antigenic Target-6 (ESAT-6) secretion system-1 (ESX-1) to replicate in the cytoplasm (37, 38) . Given these findings, it is not surprising that an array of cytosolic pattern recognition receptors is involved in the innate sensing of M. tuberculosis and can shape both the innate and adaptive immune responses (39) . Specifically, NOD2 senses muramyl dipeptide (MDP) fragments of bacterial peptidoglycan (PGN) and can oligomerize with multiple signaling intermediates to trigger cellular responses ranging from autophagy to inflammatory cytokine production (40) . It is notable that M. tuberculosis has developed an unusual variant of MDP, which is N-glycolyl modified as opposed to the N-acetylated MDP produced by most other types of bacteria. This structural difference imparts the unique capacity of mycobacterial MDP to trigger type I IFN production (i.e., IFN-α/β) in macrophages through an alternative receptor-interacting protein kinase-2 (RIP2) and interferon regulatory factor-5 (IRF5) pathway. Importantly, this recognition is dependent on ESX-1-mediated phagosomal membrane perturbation and escape of MDP fragments into the cytosol (41) . It is likely that M. tuberculosis promotes type I IFN signaling, which antagonizes host-protective IL-1β and IFN-γ pathways. Furthermore, studies of type I IFN receptor-deficient mice have shown that IFN-α/β has no effect on M. tuberculosis growth in the lungs and even promotes bacterial replication at extrapulmonary sites (42) (43) (44) .
Recently, considerable attention has been paid to the role of NLRs in microbial infections. Upon activation, these intracellular sensors are recruited to a large macromolecular complex termed the "inflammasome" via their pyrin (PYD)-containing domains by the PYD and caspase activation and recruitment (CARD) domain containing adaptor protein ASC, resulting in the processing of pro-caspase-1 into its enzymatically active form that leads to processing and secretion of IL-1β, IL-18, and IL-33. In many cases this form of activation leads to a type of programmed cell death termed pyroptosis (45, 46) . There have been a number of studies examining the role of NLRs, particularly NLRP3, and terminal effectors of the inflammasome during M. tuberculosis infection in vitro and in vivo. While M. tuberculosis has been shown to potently activate the inflammasome in an ESAT-6-dependent fashion in both mouse and human macrophages, leading to IL-1β release and pyroptosis (47, 48) , similar studies using mouse dendritic cells have revealed NLRP3-and ASCindependent IL-1β secretion without pyroptotic cell death (49) . Mice that are genetically deficient in production or response to IL-1β have increased susceptibility to acute disease following aerogenic infection with virulent M. tuberculosis, and this phenotype appears to be independent of TLRs, NLRP3, caspase-1, and ASC (50-52). On the other hand, these sensors may cooperate in maintaining granuloma architecture and stabilizing M. tuberculosis virulence during the chronic stage of the disease in mice. If so, then it is possible that inflammasome activation may be deliberately triggered in some situations by virulent mycobacteria as part of a program for promoting persistent infection rather than runaway virulence.
EVASION OF C-TYPE LECTIN RECEPTOR SIGNALING
The immunogenic properties of mycobacterial cord factor, trehalose-6,6′-dimycolate (TDM), have been known since TDM was purified from pathogenic mycobacteria in the early 1950s by Bloch and colleagues (53) . This led to the development of a cell-free model of granuloma development by which TDMs emulsified in oil droplets were injected into experimental animals, resulting in granuloma-like structures with cellular composition quite similar to natural M. tuberculosis granulomas (54) . Recently, a number of specific genes responsible for the inflammatory effects of TDMs from pathogenic mycobacteria were identified. These included the cyclopropyl synthetase genes pcaA and cmaA2, which upon deletion led to different modifications of mycolate structure and altered host immune responses (55, 56) . TDM from the pcaA mutant of M. tuberculosis, containing α-mycolates that lack cyclopropyl groups along with an overabundance of ketomycolates, had a significantly reduced capacity to elicit pro-inflammatory cytokine production from macrophages and form nascent granulomas in wild-type mice (57) . In contrast, the cmaA2 mutant of M. tuberculosis, which selectively lacks mycolate cyclopropyl groups in the transconfiguration, is hypervirulent in mice, and TDMs isolated from this strain were 5-fold more potent in stimulating tumor necrosis factor-α (TNF-α) production from macrophages (58) .
Another gene involved in mycolate modification was discovered to have a significant impact on the regulation of IL-12p40 in murine macrophages. Identified during a genome-wide transposon mutagenesis screen, the enzyme encoded by the mmaA4 gene catalyzes the introduction of a hydroxyl group at the distal carbon of the meromycolate chain during mycolic acid synthesis to produce a hydroxymycolate intermediate. TDMs from this mutant are unusually potent in stimulating IL-12p40 production from macrophages, which is inhibited by wild-type TDM. In addition, M. tuberculosis with a deletion of the mmaA4 gene is highly attenuated for growth and virulence in mice, and this phenotype is directly linked to the enhanced production of IL-12p40 (59) .
In 2009 the mammalian receptor for TDMs was identified as the macrophage-inducible C-type lectin receptor mincle (60) . This receptor initiates cellular activation and cytokine production through a Syk-CARD9-Bcl10 intracellular pathway (61) . It is important to note that CARD9 knockout mice, while able to mount an efficient adaptive immune response, are acutely susceptible to aerogenic M. tuberculosis infection with uncontrolled bacterial growth and aggressive pulmonary neutrophilia (62) . Mincle activation by mycolates leads to the production of cytokines important for the development of T H 1 and T H 17 CD4 T cells, in part by amplifying IL-1R signaling (63, 64) . While mincle appears to be critical for the adjuvant effect of TDMs both in vitro and in vivo and has been implicated in TDM-induced neutrophilia (65) , an extensive survey of aerogenic infection in mincle-deficient mice revealed no significant differences compared to wild-type littermates in organ pathology or bacillary burden (66) .
These data appear to demonstrate that M. tuberculosis has fine-tuned mycolate biosynthesis to achieve a level of inflammation sufficient to promote granuloma development without triggering excessive IL-12p40 production. The modulation of the IL-12p40 response by M. tuberculosis may represent a strategy for achieving an ideal balance that allows the bacterium to persist or proliferate slowly without bringing about rapid death of the host organism.
INHIBITION OF MACROPHAGE EFFECTOR FUNCTION AND PHAGOSOME MATURATION
Macrophages are the primary host cell type in which M. tuberculosis resides during infection, and the bacilli have evolved a number of sophisticated mechanisms to persist and replicate in this environment (67) . One of the earliest virulence traits described for M. tuberculosis is its ability to block the fusion of phagosomes with lysosomes in infected macrophages (68) (69) (70) (71) . This mechanism is generally believed to be important for allowing the organism to avoid exposure to lysosomal hydrolases, low pH, and other components of lysosomes with bactericidal properties. The mechanisms by which M. tuberculosis inhibits phagosome maturation and phagosome-lysosome fusion has been an area of active investigation but remains incompletely understood. Initial molecular and cell biological studies showed that mycobacterial phagosomes failed to incorporate vacuolar ATPases, which could account for their inability to acidify (72) . In addition, studies showed that mycobacterial phagosomes retained a protein known as coronin-1 or TACO on the cytoplasmic face of their limiting membranes, whereas phagosomes that undergo fusion with lysosomes tended to rapidly lose the association with this protein (73) . Such studies provided confirmation and molecular details of the inhibition of the normal process of phagosome-lysosome fusion in M. tuberculosisinfected macrophages but did not offer direct insight into the mechanism by which the pathogen controls this process.
More recently, studies have identified a serine/threonine kinase encoded by the M. tuberculosis pknG gene as a potential effector of the inhibition of phagosomelysosome fusion. Expression of the product of this gene (M. tuberculosis protein kinase G) in the nonpathogenic species Mycobacterium smegmatis was sufficient to cause this inhibition, and deletion of pknG from M. tuberculosis caused the bacteria to localize to lysosomelike structures (74) . Subsequent studies have identified a small secreted protein tyrosine phosphatase encoded by the ptpA gene to inhibit vacuolar acidification by binding to the H-subunit of the macrophage vacuolar-H + -ATPase (75) . In addition, an acid-and phagosome-regulated (aprABC) locus was discovered in virulent mycobacteria that is uniquely involved in responding to acidic stress within the phagosome. These genes require acid sensing by the phoPR operon, which leads to aprABC expression and the modulation of cell wall lipid synthesis and sequestration, enabling survival at low pH (76) . M. tuberculosis also uses a specialized adenylate cyclase encoded by the gene Rv0386 that causes a transient cyclic AMP burst in the macrophage cytosol that promotes protein kinase A (PKA)-dependent phosphorylation of the transcriptional element CREB (cyclic AMP response element binding) and confounds inflammatory signaling (77) .
PREVENTION OF AUTOPHAGY BY M. TUBERCULOSIS
Autophagy is a homeostatic and inducible process by which the cells can eliminate damaged organelles or other unwanted structures within the cell. The process is initiated by the formation of a double membraneenclosed structure that forms an autophagic vacuole that engulfs organelles or other inclusions in the cytosol. The material engulfed by the vacuole can then be digested following fusion with lysosomes (78) . Moreover, it has been shown that many pathogens, including intracellular bacteria such as M. tuberculosis, can become localized to autophagic vacuoles within host cells (79) .
In the case of M. tuberculosis-infected cells, it has been shown that autophagy can contribute to the killing and clearance of the bacteria (79) (80) (81) . Nutrient starvation or IFN-γ treatment can induce autophagy in M. tuberculosis-infected cells, and phagosomes containing the bacilli acquire lysosomal markers and become acidified during this process. In addition, M. tuberculosis localization to autophagosomes in infected macrophages is markedly increased by treatment of the cells with lipopolysaccharide, defining a TLR4-mediated pathway for induction of autophagy (82) . Several reports also indicate that through ESX-1-dependent phagosomal permeabilization, M. tuberculosis initiates activation of macrophage autophagy by intracellular DNA sensing (STING), vitamin D, and IL-1R-dependent pathways (83) (84) (85) . Furthermore, these effects have been shown to decrease the survival of M. tuberculosis in cells induced to undergo autophagy, and animals that have conditionally knocked out autophagic functionality in myeloid cells (Atg5 flox/flox LysM Cre ) are acutely susceptible to aerogenic infection with M. tuberculosis and have unrestrained bacterial replication, elevated inflammatory cytokine production, and large focal pulmonary abscesses (85, 86) . In light of these findings, it is reasonable to speculate that M. tuberculosis may target this pathway to increase its intracellular survival, and recently data have begun to appear that support this possibility (87) . Additionally, several reports have indicated that the enhanced intracellular survival (eis) gene of M. tuberculosis encodes a temperature-stable hexameric protein that inhibits phagosome maturation, reactive oxygen species (ROS) production, and autophagy through the direct acetylation of a specific c-Jun N-terminal kinase (JNK)specific phosphatase (88) (89) (90) .
PE AND PE_PGRS PROTEINS AS POTENTIAL MEDIATORS OF IMMUNE EVASION
Sequencing of the genome of M. tuberculosis H37Rv revealed the presence of a large family of related genes encoding what have come to be known as PE proteins, with 99 member genes accounting for nearly 4% of the organism's whole genome (91, 92) . This enigmatic gene family encodes proteins that are primarily characterized by the presence of a characteristic proline and glutamic acid (PE) motif. A large subfamily of these proteins is made up of the 61 PE_PGRS proteins, which also contain C-terminal domains characterized by polymorphic guanosine-cytosine-rich sequences (PGRSs), which vary in size, sequence, and repeat copy numbers (93) . There is much interest in this gene family and its role in mycobacterial virulence since genomic analyses show that the marked expansion of PE and PE_PGRS proteins is seen only in M. tuberculosis and other pathogenic species of mycobacteria (94) . Therefore, it is reasonable to speculate that they play an important role in the pathogenesis and persistence of M. tuberculosis.
Many of these proteins are located at the mycobacterial cell wall and membrane (95) (96) (97) , and this localization at the M. tuberculosis-phagosomal interface may indicate that these proteins play an important role in host-pathogen interaction. This localization also suggests a requirement for secretion, and while these proteins do not contain the canonical N-terminal signal peptide, specialized secretion systems may play a role in the export of PE_PGRS proteins from the bacterial cell. Consistent with this, a recent study identified ESX-5, one of the type VII secretion systems of M. tuberculosis, as the most likely candidate for the translocation of some PE_PGRS proteins across the bacterial cell membrane (98) . Early work by Ramakrishnan and colleagues implicated PE_PGRS proteins from Mycobacterium marinum as virulence factors in a Xenopus model of infection. They demonstrated that two PE_PGRS genes were upregulated within granuloma-like structures of infected frogs and that mutant strains replicate poorly in macrophages (99) . Initial studies on M. tuberculosis PE_PGRS genes have focused on PE_PGRS33 as the prototypical family member (100) . Constitutive expression of PE_PGRS33 in nonpathogenic M. smegmatis was shown to enhance intramacrophage survival, necrosis of infected macrophages, and TNF-α expression and to reduce nitric oxide (NO) production (101) . Ectopic expression of PE_PGRS33 in mammalian Jurkat T cells induces apoptosis and can be blocked by Bcl-2 (102). Subsequently, it was shown that induction of apoptosis by PE_PGRS33 is mediated by TLR-2dependent release of TNF-α (103) .
A limited comparative study has shown that PE_PGRS33, -16, and -26 are differentially regulated during M. tuberculosis infection of macrophages and in the lungs of mice (104) . These have also been shown to differentially modulate the host cytokine response depending on the specific PE_PGRS protein evaluated. While PE_PGRS33 expressing M. smegmatis enhances production of TNF-α and IL-10, it reduces IL-12p40 and NO production (101) . On the other hand, expression of M. tuberculosis PE_PGRS16 in M. smegmatis has been shown to enhance IL-12p40 and NO while suppressing the level of IL-10, in contrast to PE_PGRS26, which has the opposite effect (105) . Subsequent examinations of another family member, M. tuberculosis PE_PGRS62, demonstrated an ability to suppress the expression of IL-1β, IL-6, and the inducible nitric oxide synthase (iNOS) and arrest phagosomal maturation (106, 107) . Collectively, these data demonstrate specific functions for individual PE_PGRS family members in modulating macrophage effector functions.
It is well known that proximal interactions of M. tuberculosis within macrophages result in a number of Ca 2+ signaling events critical for phagosome maturation (6, 108, 109) . It has been suggested from in silico analysis of the PE_PGRS family that the PGRS domain forms a Ca 2+ -binding motif known as a parallel β-roll or parallel β-helix typical of many calcium-binding proteins. Interestingly, of the entire PE_PGRS family, only five members (PE_PGRS8, -12, -17, -60, and -62) lack this putative domain (110) . These observations suggest that PE_PGRS proteins could be involved in controlling Ca 2+dependent events within host cells or tissues, although direct studies of this possibility are not yet available.
Overall, it appears that the PE and PE_PGRS proteins are likely to represent major components of immune evasion by M. tuberculosis, and a great deal remains to be learned about the precise functions of these proteins during different stages of mycobacterial infection.
EVASION OF ADAPTIVE IMMUNITY
Many of the innate immune evasion mechanisms described above also have major downstream effects on the development of adaptive immunity. In addition, it is well recognized that successful intracellular pathogens possess multiple, highly evolved mechanisms to limit T cellmediated immunity by disrupting antigen processing and presentation (111, 112) . This is well established to be the case for M. tuberculosis, which likely uses multiple sophisticated and precisely targeted mechanisms for inhibiting or manipulating all of the known pathways for antigen presentation to T cells (113, 114) .
INFECTION OF ANTIGEN PRESENTING CELLS BY M. TUBERCULOSIS
The fact that M. tuberculosis directly and efficiently infects professional antigen-presenting cells is likely to have a major impact on how this pathogen subverts and evades antigen-specific T cell responses. Macrophages are the major cell type infected by M. tuberculosis in vivo and provide the most important site for intracellular replication. Macrophages also have the capability of presenting peptides to effector T cells on both major histocompatibility complex (MHC) class I and class II molecules, and they depend on activation by T cells to exert their microbicidal functions against mycobacteria such as nitric oxide production (115) . While antigen presentation by macrophages is likely to be critical to expression of the antimycobacterial functions of previously primed effector or memory T cells, it is unlikely that macrophages are effective at priming the initial T cell responses of naïve T cells against mycobacterial antigens. This function is provided by various subsets of dendritic cells, which are highly specialized to process and present all types of antigens to naïve CD4 + and CD8 + T cells. Recent studies have shown that dendritic cells are also infected at high levels during M. tuberculosis infection in mice, suggesting that direct manipulation of dendritic cell function by intracellular mycobacteria is likely to be a prominent feature of infection (116) .
The use of M. tuberculosis engineered to express green fluorescent protein (GFP) has allowed the accurate localization of the bacteria in vivo after infection. This technique has been used to show that lung myeloid dendritic cells (CD11c high CD11b high ) are among the major cell types that become infected after introduction of aerosolized M. tuberculosis into the lungs, along with alveolar macrophages (CD11c high CD11b low ), recruited interstitial macrophages (CD11c low CD11b low ), monocytes, and neutrophils (116) . Dendritic cells infected in the lung are then able to transport mycobacterial antigens to the mediastinal lymph nodes to initiate the adaptive immune response. However, macrophages and dendritic cells that have not been sufficiently activated do not seem capable of killing the intracellular bacteria and serve as a reservoir of M. tuberculosis that could be responsible for the dissemination and delay of the adaptive immune response. These infected phagocytes may serve the role of "Trojan horse" by carrying the bacteria away from the primary focus of infection to widely seed many other tissues. Because of the marked migratory potential of tissue dendritic cells, these cells may be particularly likely to play a significant role in bacterial dissemination (117, 118) .
DISRUPTION OF DENDRITIC CELL MATURATION BY M. TUBERCULOSIS
A number of studies have shown that M. tuberculosis infection of dendritic cells can alter the normal process of maturation of these cells, which is crucial to their ability to efficiently prime antigen-specific T cells. At least two studies using cultured human monocyte-derived dendritic cells have found that these cells fail to show normal maturation following infection with M. tuberculosis, as indicated by a lack of rapid mobilization of MHC class II molecules to the cell surface that is normally associated with the maturation process (119, 120) . Other data indicate that immune evasion may occur not through a blockade of dendritic cell maturation, but rather by stimulating a poorly coordinated maturation that causes effective antigen processing to cease before M. tuberculosis antigen production begins (121) . According to this model, rapid maturation of dendritic cells infected by M. tuberculosis results in the movement of the great majority of MHC class II molecules to the cell surface, coupled with the cessation of new MHC class II molecule synthesis. This suggests that by the time peptide antigens secreted by M. tuberculosis become available for processing and loading onto MHC class II molecules in endocytic compartments, the majority of MHC class II molecules may already have moved to the cell surface to limit the pool of these molecules available for peptide loading. This "kinetic model" of immune evasion may explain how M. tuberculosis can severely restrict the ability of directly infected dendritic cells to present bacterial antigens. However, such a mechanism would not clearly apply to cross-presentation of secreted antigens by uninfected dendritic cells, which may offer a potential explanation for the apparent bias toward recognition of secreted protein antigens by T cells in M. tuberculosisinfected animals.
MODULATION OF CD4 T-HELPER CELL DIFFERENTIATION
CD4 T cells have a high level of developmental plasticity, which is likely due in part to their central involvement in immune responses to a litany of diverse pathogens. To counter the differential nature of these diverse threats, helper T cells make use of an array of differentiation programs to either limit or compromise pathogen survival (122) (Fig. 2) . It was recognized fairly early on that CD4 T cells are critical for the control of M. tuberculosis infection in mouse models and in humans (123-126). It was also quickly recognized that activation of macrophage effector functions by IFN-γproducing T H 1 cells is central to this protective effect (127) (128) (129) (130) . Subsequent studies demonstrated significant roles for FoxP3 + regulatory T cells (T reg ) and IL-17producing T H 17 cells in the development of protective immunity to M. tuberculosis (131, 132) .
It is likely that the array of pattern recognition receptors expressed by M. tuberculosis triggers the development of a priming milieu that initially favors the expansion of T reg cells, and later T H 1 and to a lesser extent T H 17 cells. Interestingly, T reg cells have been shown to expand in the lungs of M. tuberculosisinfected mice and appear to constrain the full effectiveness of T H 1 cells by delaying their homing to the lung from the mediastinal lymph node. This may be due in part to the ability of M. tuberculosis to recruit CD103 + dendritic cells to infected tissues (132) (133) (134) . A role for IL-17-producing T H 17 cells in pulmonary inflammation following aerogenic M. tuberculosis infection in mice has been demonstrated, and these cells appear to play a positive role in conferring vaccine-mediated protection (131, 135) . Such T H 17 cells are differentiated in the presence of IL-6 and IL-1β and maintained by IL-23, which are abundantly produced cytokines during active M. tuberculosis infection and following the administration of killed organisms (24, 136, 137) . Surprisingly, IL-23, a critical factor for the maintenance of T H 17 cells, appears to mediate control of M. tuberculosis infection at least in part by stimulating the CXCL13-dependent organization of B-cell follicles in the infected lung (138) . IL-17 indirectly serves as a chemoattractant for neutrophils, and recent reports have shown that apoptosis of infected neutrophils is a potent vehicle for the delivery of mycobacterial antigens to dendritic cells, facilitating the priming of naïve CD4 T cells (139, 140) . In this respect, it is intriguing to speculate that M. tuberculosis, in addition to actively inhibiting neutrophil apoptosis, may inhibit the priming of T H 17 cells to reduce neutrophil infiltration of lung tissue during disease.
The evaluation of T H 1 immunity during mycobacterial infection has been a particularly active area of investigation for more than 2 decades. Recently, considerable interest has focused on the ability of individual T H 1 cells to produce multiple cytokines (IFN-γ, TNF-α, and IL-2) upon recognition of their cognate antigens (141, 142) . The role of these so-called multifunctional T cells remains controversial during M. tuberculosis infection and also in the context of vaccine-mediated protection (143) (144) (145) (146) . However, to date, a large pool of multifunctional antigen-specific CD4 T cells in the tissues of M. tuberculosis-infected mice may represent the strongest correlate of mycobactericidal immunity yet identified, at least in mouse models (147) .
The ability to analyze antigen-specific CD4 T cells using tetramer technology has led to several interesting observations about the M. tuberculosis-specific effector memory CD4 T cell population. One such study segregated effector CD4 T cells into three populations based on surface expression of programmed death receptor-1 (PD-1) and the killer cell lectin-like receptor G1 (KLRG1) (148) . These markers delineate both selfrenewing and terminal effector subsets, as KLRG1 neg CD4 T cells that are either low or high for PD-1 expression are both weak cytokine producers that are capable of self-renewal, whereas CD4 T cells expressing high KLRG1 levels and lacking PD-1 subset produce high amounts of IFN-γ and TNF-α but do not proliferate. Interestingly, mice deficient for KLRG1 mount more efficient T cell responses against M. tuberculosis and have lower bacterial burdens compared to wildtype mice 90 days postinfection and beyond (149) . Other reports have shown that PD-1-deficient mice succumb rapidly to aerogenic M. tuberculosis infection, with large disorganized lesions composed predominantly of infiltrating neutrophils. CD4 T cells from these mice had poor multifunctionality in terms of cytokine production, and the early mortality following M. tuberculosis infection was abrogated by CD4 T cell depletion (150, 151) . While no studies to date have linked these two observations, it is reasonable to assume that KLRG1 and PD-1, rather than just serving as phenotypic markers, might have a specific role in the self-renewing to terminal effector development of M. tuberculosis-specific CD4 T cells. These data suggest that control of M. tuberculosis infection requires a delicate balance of CD4 differentiation phenotypes, and direct dysregulation of this process is likely to be an important component of immune evasion by M. tuberculosis.
SECRETED PROTEINS AS IMMUNOLOGICAL DECOYS
The highly coordinated expression of one or a small set of antigens that dominates the immune response may represent the use of immunological "decoys" by M. tuberculosis to distract the immune response and prevent it from responding against target antigens that are more This can lead to a number of different outcomes, which are largely determined by which cytokines predominate in the T cellpriming environment. Following activation, CD4 T cells can differentiate into FoxP3 + regulatory T cells (T regs ) that strongly inhibit many immune responses. A related but distinct pathway of T cell differentiation upregulates the transcription factor RORγt, leading to T H 17 cells that produce IL-17A, IL-17F, and IL-22, which promote neutrophil chemotaxis. Another possible outcome is the development into TH1 cells that express the transcription factor Tbet. These may be either self-renewing Tbet + T H 1 cells that are PD-1 + and produce low amounts of IFN-γ and TNF-α, or terminal effector T H 1 cells that are KLRG1 + and produce high levels of IFN-γ and TNF-α that stimulate macrophage effector function during M. tuberculosis infection. doi:10.1128/microbiolspec.MGM2-0005-2013.f2 relevant to host protection. In theory, these decoy proteins would contain peptides with high affinity for MHC class I and II molecules that out-compete other subdominant but potentially more important epitopes for the formation of protective effector and memory T cells. In some cases, such as with the immunodominant secreted Ag85B antigen, the protein is not essential for bacterial survival, and its expression is shut off after infection is established (152) . In this way, a subversion of the T cell response can occur in which strong responses are primed that subsequently fail to recognize the pathogen. Effector T cells primed against such decoy antigens would thus survey the body for antigenic targets that are no longer present, and would be unable to recognize infected macrophages containing bacteria that do not express the decoy epitope but instead express other antigens to which the immune system has not been primed. Once the initial targets of the primary immune response have been established, it is possible that M. tuberculosis may actively inhibit the priming of new responses against subdominant epitopes or those that are expressed in a delayed manner, thus preventing truly protective responses from developing (153) . Regulation of antigen expression in this way has been suggested to result in part from feedback loops that allow the bacterium to regulate its protein secretion systems through a process related to quorum sensing (154) .
Some support for the concept of immunological decoys in M. tuberculosis infection has recently been provided from comparative genomic studies of mycobacteria. By performing deep sequencing of the genomes of 21 strains from the M. tuberculosis complex, Gagneux and colleagues made the surprising discovery that sequences encoding human T cell epitopes were hyperconserved across strains (155) . In the same study, the sequences of 16 human T cell antigens were compared over 99 M. tuberculosis complex strains and again showed an unexpectedly high level of sequence conservation. Thus these results suggest that, rather than undergoing mutational variation and selection to escape from immunological pressure, M. tuberculosis may actually benefit from the recognition of its immunodominant epitopes by T cells.
Nonsecreted or cytoplasmic proteins of mycobacteria have generally not been found to be major antigenic targets of T cell responses in M. tuberculosis-infected animals, although humoral responses have sometimes been found against such antigens (156) (157) (158) . However, the fact that nonsecreted mycobacterial proteins do not strongly stimulate T cell responses during infection with live mycobacteria does not necessarily mean that these antigens cannot be the targets for protective T cell responses. In fact, a few studies have shown that vaccination of animals to specifically stimulate immunity against nonsecreted protein antigens can lead to a significant level of protection against subsequent mycobacterial challenge (159, 160) . This suggests that the failure of nonsecreted proteins to effectively prime MHC class I or class II restricted T cell responses during infection with M. tuberculosis could be the result of active immune evasion mechanisms. On the other hand, the observation that killed mycobacterial vaccines are less efficient than live attenuated vaccines for eliciting protective immunity argues that protein secretion may be needed to generate effective immunity (161) . Another recent report has assessed CD4 T cell recognition of all in silico-predicted HLA-DR, -DB, and -DQ binding epitopes in the M. tuberculosis genome by a large cohort of humans with latent M. tuberculosis infection. This revealed strong preferential responses to three "antigenic islands" corresponding in part to ESX secreted proteins, but also to associated components of the ESX secretion apparatus that are not themselves believed to be secreted (162) . These findings raise important issues for ongoing efforts to produce more effective vaccines, particularly since most of the target antigens that are currently being used in vaccine development are immunodominant secreted antigens that could potentially represent relatively nonprotective decoy antigens (163, 164) . More analysis of the impact of immunizing against secreted as opposed to nonsecreted target antigens will be needed to resolve this important point.
DELAYED PRIMING OF ADAPTIVE IMMUNITY IN M. TUBERCULOSIS INFECTION
A key feature of the adaptive immune response to M. tuberculosis in the lung is that it is remarkably delayed and slow to develop, which in mouse models allows the bacteria to grow uncontrolled for approximately 21 days (165) . The recent development of transgenic mice expressing TCRs specific for MHC class II-presented peptides of M. tuberculosis Ag85B and ESAT-6 has significantly enhanced the study of the early events of the adaptive immune response in the lungs after low-dose aerosol infection (166) (167) (168) . Ag85B and ESAT6 are both secreted antigens that are highly expressed during the initial stages of infection and then decline after approximately 3 weeks. Studies using adoptive transfer of T cells from these TCR transgenic mice have emphasized the slow pace of the evolution of the T cell response even against strongly expressed secreted antigens during the initial phase of pulmonary tuberculosis (166) (167) (168) . These studies also show that T cell responses in mice following aerosol infection with M. tuberculosis are initiated in the draining mediastinal lymph nodes and that this requires the transport of mycobacteria into the lymph nodes by migrating lung dendritic cells. The delay in T cell priming can be accounted for by the finding that migration of infected dendritic cells from the lung to lymph nodes is also delayed, requiring 11 to 12 days to first become detectable (116, 168) .
These findings suggest that one way in which M. tuberculosis avoids elimination by the host immune system involves delaying the onset of adaptive responses until the bacteria have established a protected niche in which they can persist permanently. Thus, while M. tuberculosis produces many secreted antigens that are highly immunogenic during the early phase of infection, the host immune system is not able to mount a rapid protective response against these to control bacterial growth. It is noteworthy that T cell responses following an aerosol M. tuberculosis infection seem to be significantly more delayed than those that develop after intravenous infection (153) , suggesting that the delay in T cell priming could be largely due to inhibitory effects of the pathogen that are exerted specifically on antigenpresenting cells of the lungs. This may reflect a specialized adaptation of this bacterium to its natural route of infection. The slow development of adaptive immunity following M. tuberculosis infection is in marked contrast to the kinetics typically observed for acute viral infections of the lung or with other intracellular bacteria such as Listeria monocytogenes (169) . In the sections that follow, we review known or postulated mechanisms that subvert, evade, or alter the kinetics of the antimycobacterial immune response by direct inhibition of key steps in antigen presentation.
MANIPULATION OF MHC CLASS II ANTIGEN PRESENTATION BY M. TUBERCULOSIS
MHC class II restricted CD4 + T cells are well known to be critical for control of M. tuberculosis infection in experimental animals and humans (165) , and it is therefore extremely probable that the MHC class II pathway for antigen presentation is targeted by the bacterium to enhance its intracellular survival and persistence. In fact, multiple mechanisms have been described by which M. tuberculosis can potentially affect antigen presentation by MHC class II molecules (Fig. 3) . As previously discussed, M. tuberculosis can efficiently block phagosome maturation and fusion with lysosomes, resulting in the maintenance of an intracellular compartment that is favorable for bacterial survival. This process also undoubtedly plays a role in restricting access of mycobacterial protein antigens to the processing machinery that generates MHC class II complexes bearing M. tuberculosis epitopes, and thus blunts the CD4 T cell response to the pathogen. In addition, a number of recent studies have provided strong connections between the process of autophagy and MHC class II presentation of peptides from intracellular proteins (80, (170) (171) (172) (173) . Since M. tuberculosis appears to actively inhibit autophagy by infected cells, this likely represents an additional mechanism for limiting the generation of MHC class II presented epitopes. Consistent with such a proposed mechanism of immune evasion, a recent study showed that autophagy enhances the efficacy of BCG vaccination by increasing mycobacterial peptide presentation in mouse dendritic cells (174) .
Studies focusing on the 19-kDa lipoprotein antigen (LpqH), a major triacylated exported cell wall protein of M. tuberculosis, demonstrated the ability of this ligand for mammalian TLR2 to globally reduce the surface levels of MHC class II molecules expressed by M. tuberculosis-infected macrophages (12, 175, 176) . This effect appears to be linked to excessive or prolonged TLR2 signaling, which reduces activity of the MHC class II transcriptional transactivator (CIITA) and also interferes with IFN-γ signaling. Detailed in vitro studies of this phenomenon revealed that isoforms of the transcription factor C/EBP that suppress transcription of CIITA are induced following TLR2-dependent stimulation of macrophages by 19-kDa lipoprotein. These C/EBP isoforms are further modified by a mitogenactivated protein kinase (MAPK) that is also activated by TLR2 signaling, and this increases their binding affinity to promoter regions I and IV of the CIITA gene to inhibit its expression (177) (178) (179) .
The reduction of MHC class II expression induced by 19-kDa lipoprotein has been shown clearly in experiments in vitro with cultured cells, but the in vivo relevance of this mechanism during infection remains unclear. Experiments in vivo showed indistinguishable levels of MHC class II on cells either expressing or lacking TLR2 in mixed bone marrow chimeras that were reconstituted with a mixture of wild-type and TLR2-deficient bone marrow (180) . This result indicates that TLR2 expression is not required on macrophages for inhibition of their MHC class II synthesis and that other mechanisms that may be independent of TLR2 could account for this effect during M. tuberculosis infection in vivo (181, 182) . Other recent in vivo data show that the decrease in MHC class II expression on lung antigen-presenting cells during infection is restricted mainly or exclusively to cells that are directly infected with mycobacteria (183). This raises the question of how the 19-kDa lipoprotein-induced downregulation of MHC class II is restricted to infected but not uninfected cells, given that this lipoprotein is secreted by the bacterium. It is possible that the lipoprotein is unstable and short-lived, so that only secretion in an autocrine manner (i.e., by cells that are directly infected) is sufficient to give TLR2 activation, or that secretion directly within the phagosomal lumen is required. In addition, experiments have not yet fully clarified what the impact of the 19-kDa lipoprotein-induced MHC class II downmodulation is on the presentation of mycobacterial protein antigens. Although inhibition of the presentation of exogenously added ovalbumin has been shown for various antigen-presenting cells purified from the lungs of M. tuberculosis-infected mice (183), it remains to be determined whether this effect is directly related to activities of the 19-kDa lipoprotein. Likewise, data are not yet available for the effect of 19-kDa lipoprotein on presentation of actual bacterial proteins produced in the infected cell. It should be noted that 19-kDa lipoprotein is only one of multiple known TLR2 ligands in M. tuberculosis, others of which include the lipoproteins LprA, LprG, and 38-kDa lipoprotein (also known as PstS-1, phoS, or phoS1), as well as the small secreted protein ESAT-6 and complex glycolipids in the LAM family (184-187). All of these M. tuberculosis-derived ligands for TLR2 could potentially contribute to the modulation of MHC class II levels, and may synergize with numerous other microbial products to influence the outcome of the adaptive immune response to M. tuberculosis.
M. tuberculosis can affect the intracellular trafficking of MHC class II molecules by interfering with cathepsins and by alkalinization of intracellular compartments (188) . Cathepsins are cysteine proteases that are essential for processing of the MHC class II-associated invariant chain (Ii), which is a necessary step in peptide loading and subsequent cell surface expression of MHC class II molecules. Studies of cathepsin S (CatS) have shown this particular member of the cathepsin family to be the most important or possibly the only protease that is capable of mediating the late steps of Ii cleavage needed to generate MHC class II molecules that can be efficiently loaded with peptide antigens (189, 190) . In vitro experiments showed that mycobacterial infection of human macrophages caused reduction of CatS activity and gene expression through the induction of the inhibitory cytokine IL-10 (191) . This was associated with an intracellular retention of MHC class II molecules and a reduced expression of peptide-loaded MHC class II complexes at the cell surface. This effect was reversed by addition of anti-IL-10 antibodies, which restored expression of active CatS and export of mature MHC class II molecules to the surface of infected cells. Other experiments showed that a recombinant BCG strain that was engineered to secrete CatS could also restore cell surface levels of MHC class II molecules (192) .
In related studies, it was reported that intraphagosomal production of urease encoded by the mycobacteria ureC gene, which hydrolyzes urea into carbon dioxide and ammonia, is also involved in disruption of MHC class II trafficking leading to intracellular retention. This is believed to be due to the effect of urease on preventing the acidification of MHC class II processing and loading compartments, which may also prevent the activity of proteases such as CatS (193) . Other reports have also implicated inhibition of expression or activity of other cathepsin proteases, such as cathepsins L and D, in the impaired processing and presentation of antigens by MHC class II in mycobacteria-infected cells (68, 194) .
EFFECTS OF M. TUBERCULOSIS ON PRESENTATION BY MHC CLASS I MOLECULES
Peptides presented by MHC class I molecules are the principal target structures of CD8 + cytolytic T cells, which are important for immunity against viruses and many other intracellular pathogens. Earlier dogmas held that peptides presented by MHC class I molecules were derived only from protein antigens that were produced in the cytosol of target cells or that somehow gained access to the cytosolic compartment. This seemed to rule out a role for MHC class I presentation of antigens from M. tuberculosis, since that organism and its antigens were believed to be confined either to endosomal compartments or to the extracellular space. This idea is now known to be incorrect for several reasons. First, it is now becoming accepted that M. tuberculosis does gain access directly to the cytosol of infected cells, as shown originally in a mouse macrophage cell line and human monocyte-derived macrophages (195) and more recently confirmed in elegant studies of infected human monocyte-derived dendritic cells (196) . Second, mechanisms by which endocytosed antigens can be processed and presented by the MHC class I system, a process generally referred to as cross-presentation, are now well documented and are strongly believed to be relevant to M. tuberculosis infection ( Fig. 4) (197, 198) .
One potential pathway for cross-presentation by MHC class I molecules of mycobacterial proteins originating in the lumen of a phagosome or phagolysosome involves their translocation to the cytosol (199) (200) (201) (202) (203) , which is proposed to involve a transporter in the phagosomal membrane referred to as the dislocon. Mycobacterial proteins transported into the cytosol in this way would be expected to undergo cytosolic processing, Newly synthesized MHC class I molecules in the endoplasmic reticulum (ER) are loaded with peptides that are produced by the cytosolic proteosome complex and transported into the ER lumen by TAP (transporter associated with antigen presentation). Additional trimming of the cytosol-derived peptides can occur as a result of aminopeptidase activity in the ER lumen. Escape of mycobacterial proteins from the phagosome into the cytosol can lead to peptide presentation by this classical MHC class I pathway (A). Mechanisms for loading of peptides onto MHC class I molecules in the lumen of the phagosome are also likely to exist. This vacuolar pathway for cross presentation (B) may involve transfer of ER membrane components (e.g., newly synthesized MHC class I complexes and TAP) to the phagosome membrane, enabling the loading of peptides generated in the cytosol. Alternatively, peptides may be generated by proteases in the phagosome lumen, and these may be loaded by a process of peptide exchange onto MHC class I molecules recycling from the plasma membrane. The so-called detour pathway (C) is a third way that peptides from a vacuolar intracellular pathogen such as M. tuberculosis can be crosspresented by MHC class I. In this case, an infected cell must first die by apoptosis, and the released apoptotic vesicles carry the mycobacterial antigens into uninfected dendritic cells. Current evidence suggests that all of these pathways are likely to be actively inhibited or effectively bypassed during M. tuberculosis infection (see text for details). doi:10.1128/microbiolspec.MGM2-0005-2013.f4 which involves polyubiquitination, proteolysis by the proteosome, and ultimately transport into the lumen of the endoplasmic reticulum (ER) by the transporter associated with antigen processing (TAP), where binding to nascent MHC class I molecules occurs with high efficiency (204) . The identification of the dislocon remains controversial, although it is postulated to be related or possibly identical to protein-transporting complexes found on the ER membrane, such as Sec61, which translocates proteins into the ER lumen, or the AAA-ATPase p97, which dislocates proteins out of the ER as part of the ER-associated degradation (ERAD) pathway (205) . In support of this, proteomic analysis of isolated phagosomes has detected the presence of Sec61 and the AAA-ATPase p97 (206) , although these findings are of uncertain significance due to possible contamination of phagosome preparations with ER membranes (207) .
In the case of M. tuberculosis-infected cells, it is possible that the bacterium itself may cause leakiness of the phagosomal membrane, and this could allow bacterial proteins to enter the cytosolic processing pathway. For example, the secreted M. tuberculosis protein ESAT-6 and its chaperone partner CFP-10 have been found to have membrane-disrupting properties (208) , suggesting that production of these proteins in the phagosome lumen could be responsible for leakage into the cytosol. In support of such a mechanism, it was shown that M. tuberculosis infection of cells facilitated the MHC class I presentation of endosomally delivered ovalbumin through a process that required the presence of live bacteria (200) . In addition, the previously documented escape of M. tuberculosis bacilli into the cytoplasm of human cultured dendritic cells was shown to require an intact RD1 locus, which encodes the ESAT-6 and CFP-10 proteins and their secretion apparatus (196) . However, whether dendritic cells remain competent to process and present antigens after M. tuberculosis has undergone escape into the cytosol is unclear, since these cells are likely to rapidly undergo necrotic cell death that is triggered by the bacteria (209, 210) . Presumably, this pathway would be less effective for nonsecreted bacterial protein antigens, which would remain within the phagosome and would thus be predicted to favor the presentation of secreted bacterial proteins.
An alternative mechanism that does not depend on phagosomal escape of antigens into the cytosol is the vacuolar model for cross-presentation. This proposes that peptides derived from bacterial proteins are generated within the phagosomal lumen and loaded directly on MHC class I molecules that recycle through the endocytic system ( Fig. 4) (198, 211) . This process requires the presence of proteases within the phagosome that can cleave the mycobacterial proteins to generate the peptides required for loading MHC class I molecules, and could potentially be relevant for both secreted and nonsecreted bacterial proteins if sufficient degradation of the bacterial cells occurs within the phagosome lumen. Although it is unclear to what extent this vacuolar pathway may account for cross-presentation of antigens by MHC class I in M. tuberculosis-infected cells, there is some evidence that peptides from Ag85B can be loaded and presented in this way (68, 212) . Whether M. tuberculosis actively interferes with MHC class I presentation mediated by either the cytosolic or vacuolar cross-presentation pathways is unknown. However, one study has reported that the M. tuberculosis 19-kDa lipoprotein can reduce processing of protein antigens by the vacuolar pathway for MHC class I presentation (213) . In addition, it would be anticipated that the previously discussed inhibition of phagosome-lysosome fusion, prevention of phagosome acidification, and downmodulation of cathepsins associated with M. tuberculosis infection would all interfere with a vacuolar MHC class I cross-presentation pathway.
Another pathway for cross-presentation of antigens by MHC class I molecules exists that has been more strongly implicated in CD8 + T cell responses to M. tuberculosis. This is known as the "detour pathway," and it depends upon the uptake by uninfected antigen-presenting cells of bacterial antigens originating from infected cells that have undergone death by apoptosis ( Fig. 4) (214) (215) (216) . Although the mechanisms involved in this antigen transfer are not completely resolved, it has been shown that M. tuberculosis-infected macrophages that are induced to undergo apoptosis by serum starvation shed subcellular vesicles that are thought to be derived from membrane blebs of the dying cells. These contain bacterial proteins and lipids and can be efficiently taken up by healthy, uninfected dendritic cells (216) . Antigens taken up this way are delivered to a TAP-dependent pathway for MHC class I presentation and can therefore prime CD8 + T cell responses. Interestingly, the detour pathway also appears to be effective for uptake of lipid antigens for CD1 presentation but does not seem to enhance MHC class II restricted antigen presentation (214, 216) .
Arguing in favor of the relevance of the detour pathway to immune responses against M. tuberculosis is the well-documented observation that pathogenic mycobacteria actively block the ability of infected macrophages to undergo apoptosis (217-220) and most likely escape eventually from infected cells by causing a form of necrotic cell death (210, 221, 222) . M. tuberculosis and other pathogenic mycobacteria appear to have evolved powerful mechanisms for controlling the process of host cell death, and this is likely to be a key factor in the survival and persistence of these bacteria in immunocompetent hosts. Recently, two genes of M. tuberculosis that are directly involved in blocking apoptosis of infected macrophages have been identified. One of these is secA2 (Rv1821), which encodes a component of a virulencerelated secretion system and is known to be involved in the transport of the enzyme superoxide dismutase (SodA) out of the bacterial cell. Given that SodA has also been implicated in the inhibition of apoptosis (223) , it seems likely that secretion of this enzyme by intracellular mycobacteria is important for controlling the levels of reactive oxygen intermediates that may act as a trigger for apoptosis if present at sufficiently high levels (224) . The other identified M. tuberculosis antiapoptosis gene is nuoG (Rv3151), which encodes a subunit of the large, proton-extruding type I NADH dehydrogenase complex in the mycobacterial membrane (225) . In support of the relevance of anti-apoptosis mechanisms to the ability of M. tuberculosis to evade presentation by the detour pathway, it has been shown that a mutant strain of M. tuberculosis with a deletion of the secA2 gene not only fails to block macrophage apoptosis, but also concurrently stimulates markedly enhanced CD8 + T cell priming (226) . Along similar lines, it has been reported that a recombinant strain of BCG that induces increased levels of apoptosis of infected macrophages produces greater protective immunity against M. tuberculosis challenge when used as a vaccine in mice (227) . Thus, the blockade of apoptosis and induction of necrosis may be one of the main strategies by which M. tuberculosis evades or delays antigen presentation by MHC class I molecules.
Several observations also suggest a role for the PE_PGRS family of proteins in the suppression of MHC class I-mediated antigen presentation to CD8 + T cells in responses to M. tuberculosis infection. It has been observed that these transfections of mammalian cells with PE_PGRS16 and -62 inhibit ubiquitin-dependent proteosomal degradation, potentially reducing the generation of MHC class I-presented peptides (228) . Additionally, it has been reported that both in-frame and frameshift mutations are frequently observed in a number of genes encoding various PE_PGRS proteins in clinical isolates of M. tuberculosis, with the majority occurring within the PGRS repeat domain (229, 230) . It has been speculated that this high level of mutation could reflect a mechanism for generating rapid antigenic variation to facilitate escape from CD8 + T cells or other adaptive responses (91) .
INFLUENCE OF M. TUBERCULOSIS ON LIPID ANTIGEN PRESENTATION BY CD1
M. tuberculosis contains abundant and diverse lipids in its cell wall, and the presentation of some of these by CD1 molecules may account for a significant component of T cell-mediated immunity in humans (231) . Consistent with a proposed role in host resistance to mycobacteria, there have been suggestive data that M. tuberculosis may interfere with lipid antigen presentation by CD1 molecules. Since macrophages in general do not express the group 1 CD1 molecules (CD1a, CD1b, and CD1c), the transfer of lipids from infected cells to uninfected dendritic cells may be critical for mycobacterial lipid presentation by CD1. Interestingly, one study has shown that this lipid transfer may occur by the detour pathway described above for MHC class I cross-presentation, which depends on the ability of an infected macrophage to undergo death by apoptosis (214) . Thus, the ability of M. tuberculosis to block apoptosis of infected cells may also have important implications for evasion of lipid antigen presentation by CD1. It has also been suggested that apolipoprotein E produced by macrophages could function as a carrier to shuttle lipids from infected cells to dendritic cells (232), although whether this occurs in M. tuberculosis infection or is in any way blocked by the bacterium remains to be determined.
Direct evidence for immune evasion mechanisms targeting CD1 presentation was provided by one provocative study showing a dramatic decrease of group 1 CD1 surface expression following infection of human monocyte-derived dendritic cells in vitro with virulent M. tuberculosis. In this case, the reduced CD1a, CD1b, and CD1c expression was determined to be associated with reduced mRNA transcripts, suggesting a mechanism by which the bacterium represses the transcription of CD1 genes (233) . In addition, a few studies have shown that M. tuberculosis infection of monocytes may impair their upregulation of CD1 expression during subsequent differentiation into dendritic cells (234, 235) . Although some of these findings appear quite dramatic and biologically significant, the mechanisms responsible have not been explored, and the potential significance has not yet been extended to in vivo models. Given that CD1 molecules are generally loaded with their antigens within endocytic compartments (236) , the ability of M. tuberculosis to arrest phagosome maturation and prevent acidification of endosomal compartments in which it resides could potentially interfere with CD1-dependent antigen presentation.
Natural killer T cells (NKT cells) recognize lipid
antigens presented by the CD1d molecule (also known as group 2 CD1). These cells can produce large amounts of IFN-γ when activated and have been proposed to serve as part of the first line of defense against many pathogens. NKT cells appear to be activated during mycobacterial infection in mice, and when activated early in M. tuberculosis infection by the glycolipid ligand α-galactosylceramide, they can slow the progression of disease (237) . It has also been shown that the transfer of additional NKT cells into wild-type mice can increase their resistance to M. tuberculosis (238) . Surprisingly, mice that are NKT cell deficient due to deletion of genes for CD1d (CD1d -/mice) or for the Jα segment of the NKT cell TCR (Jα18 -/mice) have generally not been found to have altered susceptibility to M. tuberculosis infection (239) (240) (241) . This raises the possibility that CD1d presentation or other factors involved in the activation of NKT cells may be downmodulated by M. tuberculosis infection, although this has not yet been directly demonstrated.
SUMMARY AND CONCLUSIONS
It is clear from a wide array of experimental evidence and clinical observations that the remarkable success of M. tuberculosis as a human pathogen requires a sophisticated program for control of host immune responses by the bacilli. Given that the genome of M. tuberculosis has most likely evolved over millennia to meet the challenges of an aggressive mammalian immune system, it is not surprising that immune evasion programs expressed by this organism interfere with many of the known pathways of mammalian innate and adaptive immunity.
While the examples of immune evasion mechanisms discussed in this chapter are quite numerous, they most likely represent only a fraction of the processes by which this remarkable pathogen achieves its extraordinary ability to persist within the human host. The integration of high-throughput platforms for the study of host and microbial responses, along with recent advances in computational analyses, will likely aid in the development of a comprehensive map of the immune evasion networks at play during M. tuberculosis infection and facilitate our understanding of this extraordinarily complex host-pathogen relationship. As M. tuberculosis infection remains a global public health problem of the greatest magnitude, the development of a comprehensive understanding of immune evasion by this organism remains a central goal in the quest for more effective vaccines and treatments for tuberculosis.
